Company news

NovAccess Global Inc. news in 2022

NovAccess Global Inc.'s news releases, calls and decks from 2022, newest first.

View company

NovAccess Global Announces Initial Fireside Chat with Glioblastoma Patient Advocate

November 21, 2022

NovAccess Global Appoints Healthcare IP Consultant Dr. Peter Weinstein to Scientific Advisory Board

November 9, 2022

NovAccess Global Announces Virtual Annual Shareholders' Meeting

November 7, 2022

NovAccess Global Receives FDA Approval of Orphan Drug Application for TLR-AD1

October 25, 2022

NovAccess Global Announces Fireside Chat with Board Member Perspectives

October 19, 2022

NovAccess Global Announces Fireside Chat Series for the Investment Community

September 28, 2022

NovAccess Global Announces Effectiveness of Form S-1 Registration Statement

September 21, 2022

NovAccess Global Announces Uplisting to OTCQB

August 9, 2022

OTC Markets Group Welcomes New OTCQB Companies – August 8

August 8, 2022

CORRECTION: NovAccess Global Announces Filing of Orphan Drug Application for TLR-AD1

July 18, 2022

NovAccess Global Announces Filing of Orphan Drug Application for TLR-AD1

July 18, 2022

NovAccess Global CEO Dwain Irvin Featured on MoneyTV

June 13, 2022

Decks in 2022